Seoul National University Bundang Hospital
Seongnam, 463-707, South Korea
NCT Number: NCT01508481
Emerging evidence suggests that vitamin D [25-hydroxyvitamin D; 25(OH)D] may play a role in the etiology of type 2 diabetes. Vitamin D levels are lower in those with type 2 diabetes and impaired glucose tolerance (IGT) compared with those with normal glucose tolerance (NGT). In addition, a few prospective studies have shown a significant inverse association of baseline serum 25(OH)D with incident diabetes. To date, however, the exact mechanisms through which vitamin D affects diabetes risk are not yet fully known, particularly whether vitamin D plays a role in insulin resistance (IR) and/or b-cell dysfunction, the main pathophysiological disorders underlying type 2 diabetes. So, the investigators plan to examine the prospective associations of baseline vitamin D [25-hydroxyvitamin D; 25(OH)D] with insulin resistance (IR), b-cell function, and glucose homeostasis in subjects at risk for type 2 diabetes.
Looking for future studies?
Notify Me30 year and older
All sexes
Observational
Seongnam, 463-707, South Korea
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 5 years
Incidence of diabetes defined by American Diabetes Association criteria
Time frame: 5 years
Pancreatic beta cell function assessed by homeostasis model
Time frame: 5 years
Insulin resistance assessed by homeostasis model
Seoul National University Bundang Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07172269
Diabete Mellitus, Diabetes Mellitus
Baghdad, Iraq
View Trial DetailsNCT04114903
Body Weight, Cannabis Use
Boulder, Colorado, United States
View Trial DetailsNCT04738799
Diabetes Mellitus, Diabetes Mellitus, Type 2
New York, United States
View Trial DetailsNCT02725593
Diabetes Mellitus, Diabetes Mellitus, Type 2
New Haven, Connecticut, United States
View Trial Details